• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . The cost and cost drivers of delivering COVID-19 vaccines in low- and middle-income countries: a bottom-up costing study of rollouts in s

tetano

Editor, Senior Moderator
PLoS One


. 2026 Feb 2;21(2):e0341964.
doi: 10.1371/journal.pone.0341964. eCollection 2026.
The cost and cost drivers of delivering COVID-19 vaccines in low- and middle-income countries: a bottom-up costing study of rollouts in seven countries

Flavia Moi[SUP] 1 [/SUP], Văn Minh Nguyễn[SUP] 2 [/SUP], Rachel Archer[SUP] 3 [/SUP], Tozé Namalela[SUP] 4 [/SUP], Christina Banks[SUP] 5 [/SUP], Tarek Hossain[SUP] 6 [/SUP], Afroja Yesmin[SUP] 6 [/SUP], Cathbert Tumusiime[SUP] 7 [/SUP], Charlotte Muheki[SUP] 7 [/SUP], Kelsey Vaughan[SUP] 8 [/SUP], Elise Smith[SUP] 8 [/SUP], Rafael Deo Estanislao[SUP] 9 [/SUP], Pierre Z Akilimali[SUP] 10 [/SUP], Hong Thi Duong[SUP] 11 [/SUP], Chien Chinh Vien[SUP] 12 [/SUP], Amélia Dipuve[SUP] 13 [/SUP], Pedro Marizane Pota[SUP] 14 [/SUP], Monjurul Islam[SUP] 15 [/SUP], Paul Kiggundu[SUP] 16 [/SUP], Okello Ayen Daniel[SUP] 16 [/SUP], Sarah De Los Reyes[SUP] 17 [/SUP], Jeremie de Guzman[SUP] 18 [/SUP], Christelle Cuevas[SUP] 18 [/SUP], Primrose Nakazibwe[SUP] 19 [/SUP], Carl Schutte[SUP] 8 [/SUP], Minh Van Hoang[SUP] 2 [/SUP], Laura Boonstoppel[SUP] 1 [/SUP]


Affiliations
Abstract

Introduction: While COVID-19 vaccines were crucial in containing the pandemic, there is limited evidence on the cost of delivering them in low- and middle-income countries. We estimated the cost of delivering COVID-19 vaccines in Bangladesh, Côte d'Ivoire, the Democratic Republic of the Congo, Mozambique, the Philippines, Uganda, and Vietnam.
Methods: We retrospectively estimated the financial and economic cost of COVID-19 vaccine delivery from a payer perspective, using a bottom-up approach. Cost data were collected from 290 sites, while qualitative interviews were conducted with 192 key informants. We estimated volume-weighted average costs per dose in 2022 USD, for introduction phases, delivery modalities, and strategies.
Results: The financial cost per dose ranged from $0·29-$2·18 across countries, driven by per diem and supplies. The economic cost per dose ranged from $1·14-$9·50, driven by the cost of labor. Newly hired health workers were a cost driver only in the Philippines. The economic delivery cost per dose was inversely correlated with daily vaccine volume delivered at vaccination sites. Similarly, delivering through campaigns came at a lower unit cost than continuous delivery, and when programs scaled up, the cost per dose decreased dramatically. Political prioritization, health workers' commitment, and volunteers were highlighted as success factors, while resource constraints at implementation level and health workers shortages were flagged as key challenges.
Conclusion: Our findings demonstrate how under-resourced health systems managed to deliver massive amounts of vaccines with relatively few resources. However, they also expose significant gaps and inefficiencies, and underscores the need to invest in resilient health systems to improve future pandemic responses.


 
Back
Top Bottom